Shandong Sinobioway Biomedicine Co Ltd (002581) — Capital Reinvestment Ratio
Shandong Sinobioway Biomedicine Co Ltd (002581) has a Capital Reinvestment Ratio of 0.13x as of December 2024, meaning it reinvests 0% of its operating cash flow (CN¥41.76 Million) in capital expenditures (CN¥5.48 Million). See cash generation quality of Shandong Sinobioway Biomedicine Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shandong Sinobioway Biomedicine Co Ltd Capital Reinvestment Ratio (2007–2020)
This chart tracks Shandong Sinobioway Biomedicine Co Ltd's Capital Reinvestment Ratio across 14 annual periods.
Annual Capital Reinvestment Ratio for Shandong Sinobioway Biomedicine Co Ltd (2007–2020)
Year-by-year Capital Reinvestment Ratio for Shandong Sinobioway Biomedicine Co Ltd from 2007 to 2020. For live market cap and broader valuation context, see 002581 market cap overview.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 3.66x | CN¥18.51 Million | CN¥67.70 Million | ▲ +388.1% |
| 2019 | 0.75x | CN¥48.41 Million | CN¥36.27 Million | ▼ -90.8% |
| 2018 | 8.17x | CN¥74.46 Million | CN¥608.27 Million | ▲ +2413.0% |
| 2017 | 0.33x | CN¥271.11 Million | CN¥88.13 Million | ▲ +23.2% |
| 2016 | 0.26x | CN¥169.32 Million | CN¥44.69 Million | ▼ -20.3% |
| 2015 | 0.33x | CN¥137.73 Million | CN¥45.62 Million | ▲ +28.8% |
| 2014 | 0.26x | CN¥80.11 Million | CN¥20.59 Million | ▼ -49.6% |
| 2013 | 0.51x | CN¥83.13 Million | CN¥42.40 Million | ▼ -48.2% |
| 2012 | 0.99x | CN¥63.04 Million | CN¥62.11 Million | ▲ +170.1% |
| 2011 | 0.36x | CN¥74.43 Million | CN¥27.15 Million | ▲ +5.4% |
| 2010 | 0.35x | CN¥85.71 Million | CN¥29.67 Million | ▲ +19.7% |
| 2009 | 0.29x | CN¥54.06 Million | CN¥15.63 Million | ▼ -56.4% |
| 2008 | 0.66x | CN¥46.89 Million | CN¥31.11 Million | ▲ +181.5% |
| 2007 | 0.24x | CN¥25.07 Million | CN¥5.91 Million | — |